![A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib](https://static-02.hindawi.com/articles/crionm/volume-2014/962526/figures/962526.fig.002.jpg)
A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
![Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients - Frontiers Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients - Frontiers](https://www.frontiersin.org/files/MyHome%20Article%20Library/575168/575168_Thumb_400.jpg)
Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients - Frontiers
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![JCM | Free Full-Text | Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research JCM | Free Full-Text | Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research](https://pub.mdpi-res.com/jcm/jcm-08-00999/article_deploy/html/images/jcm-08-00999-g001.png?1564597737)
JCM | Free Full-Text | Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research
![Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice](https://conquer-magazine.com/images/special_issues/2021/November/table-1.png)
Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice
![Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study - Sørrig - 2019 - European Journal of Haematology - Wiley Online Library Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study - Sørrig - 2019 - European Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/465ab9bb-76da-4889-8e91-54de2ba5ec84/ejh.2019.102.issue-2.cover.jpg?trick=1672619246174)
Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study - Sørrig - 2019 - European Journal of Haematology - Wiley Online Library
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d0668b16-6f13-4a1b-99c6-7416a2f7b1b3/ctm2346-fig-0002-m.jpg)